Ask who was studied
The weight-loss trial STEP 1 enrolled adults without diabetes who had obesity, or excess weight alongside a health problem linked to it.
Obesity is a health condition involving excess body weight; the person treating you can explain how the term applies to your health.
Both study groups received help with food and activity, and the trial included regular visits.
The study was funded by the medicine's maker.
Ask whether an advertised result comes from people like you and from the exact product being offered.
A closer look at the source
Average weight loss, with the comparison beside it
In STEP 1, average weight loss after 68 weeks was 14.9% in the semaglutide group and 2.4% in the dummy-shot group.
The dummy shot was a placebo: it looked like the treatment but contained no active medicine.
Those are group averages, not a promised result for an individual.
The official medicine information also lists common stomach effects, including feeling sick, vomiting, diarrhea and constipation.
Diarrhea means loose stools; constipation means trouble passing stool.
Information as of September 26, 2026.
Ask about the plan after treatment ends
Over the year after treatment stopped, people in the STEP 1 follow-up group regained roughly two-thirds of their earlier weight loss.
That describes the study group. An individual's length of treatment cannot be decided from this result.
Ask how the prescriber thinks about long-term care, cost and a possible change in treatment.
A closer look at the source
Stopping was studied too
The later study followed only some people from the original trial.
It tells us what happened to those people; it is not a prediction for everyone who stops treatment.
Read the result as a reason to discuss a continuing plan, not as a decision made for you.
Information as of September 26, 2026.
Do not transfer a trial result to a different offer
The FDA regulates US medicines; on September 26, 2026, it called claims of proven equal results for compounded and approved drugs misleading.
Compounded describes medicine prepared by a doctor or pharmacist for an individual order.
Keep the product name beside the claim when comparing care. Ask for the study behind any promised result.